Case Series of Dermatologic Events Associated With the Insulin-Like Growth Factor Receptor 1 Inhibitor Cixutumumab

Por Daher, May, Lacouture, Mario E., Rathkopf, Dana, Maki, Robert G., Keohan, Mary Louise, Gansukh, Bolorsukh, Chen, Helen, Abou-Alfa, Ghassan K.
Publicado em 2011

Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?

Por Huitzil-Melendez, Fidel-David, Capanu, Marinela, O'Reilly, Eileen M., Duffy, Austin, Gansukh, Bolorsukh, Saltz, Leonard L., Abou-Alfa, Ghassan K.
Publicado em 2010

A Phase II Study of Cixutumumab (IMC-A12, NSC742460) in Advanced Hepatocellular Carcinoma

Por Abou-Alfa, Ghassan K., Capanu, Marinela, O’Reilly, Eileen M., Ma, Jennifer, Chou, Joanne F., Gansukh, Bolorsukh, Shia, Jinru, Kalin, Marcia, Katz, Seth, Abad, Leslie, Reidy-Lagunes, Diane L., Kelsen, David P., Chen, Helen X., Saltz, Leonard B.
Publicado em 2013